COMMUNIQUÉS West-GlobeNewswire
-
Eurobio Scientific : LEVEE DE FONDS OBLIGATAIRE D'UN MONTANT DE 2,5 M€ AVEC VATEL DIRECT
31/10/2018 - 17:46 -
Sandoz receives US FDA approval for biosimilar Hyrimoz(TM) (adalimumab-adaz)
31/10/2018 - 17:30 -
Change to Executive Management: Anders Hedegaard leaves as CEO of GN Hearing
31/10/2018 - 17:21 -
Orion Biotechnology Completes Scientific Advice Meeting with MHRA
31/10/2018 - 16:19 -
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
31/10/2018 - 16:00 -
Trogarzo® Phase III Data Analysis featured During Late-Breaking Oral Presentation at HIV Drug Therapy Glasgow 2018
31/10/2018 - 15:45 -
Analyse des données de phase III de Trogarzo® présentée lors d’une présentation orale de dernière heure à HIV drug therapy Glasgow 2018
31/10/2018 - 15:45 -
Novo Nordisk A/S: Share repurchase programme
31/10/2018 - 15:33 -
Southlake Radiology Deploys Speech Recognition and Secure Healthcare Communication Platform from eRAD
31/10/2018 - 14:49 -
Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study
31/10/2018 - 14:45 -
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
31/10/2018 - 14:42 -
DLT Resolution Launches DLT Internet Assurance (Automatic Failover) - Wireless Redundancy for Broadband Clients
31/10/2018 - 14:41 -
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
31/10/2018 - 14:21 -
Alphatec Announces Participation at Stifel 2018 Healthcare Conference
31/10/2018 - 14:05 -
NSS Labs Announces Results of 2018 Data Center Security Gateway Group Test
31/10/2018 - 14:00 -
Scientus Pharma Provides Update on Buccal Cannabis Development Program
31/10/2018 - 14:00 -
CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018
31/10/2018 - 14:00 -
OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies
31/10/2018 - 14:00 -
Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference
31/10/2018 - 14:00
Pages